Orthomolecular Medicine Society Presents 36th Annual Meeting Nutritional Medicine Today
May 11, 2007 Toronto Canado and gala dinner Honoring Abram Hpffer MD/
Abram Hoffer MD Wikipedia Entry Biogaphy. Abram Hoffer (born 1917) is a Canadian psychiatrist known for the use of nutrition and vitamins in the treatment of schizophrenia, orthomolecular psychiatry.
The International Schizophrenia Foundation Lifetime Achievement Gala Dinner honouring Abram Hoffer, MD, PhD with Margot Kidder as Master of Ceremonies, Thursday, April 19, 2007, The Fairmont Royal York Hotel Toronto, Canada
R.H. Belmaker, M.D., Hoffer-Vickar Professor of Psychiatry, Ben-Gurion University. Beer-Sheva.
What is Orthomolecular Medicine? Stephen Lawson, Adminstrative Officer Linus Pauling Institute
The word "orthomolecular" was introduced by Linus Pauling in "Orthomolecular Psychiatry", his seminal 1968 article published in the journal Science.
On the Orthomolecular Environment of the Mind: Orthomolecular Theory by Linus Pauling, Ph.D.
Journal Of Orthomolecular Medicine Vol. 7, No. 1, 1995 "Varying the concentrations of substances normally present in the human body may control mental disease." - Linus Pauling
Orthomolecular Medicine is the practice of preventing and treating disease by providing the body with optimal amounts of substances which are natural to the body. The key idea in orthomolecular medicine is that genetic factors affect not only the physical characteristics of individuals, but also to their biochemical milieu. Biochemical pathways of the body have significant genetic variability and diseases such as atherosclerosis, cancer, schizophrenia or depression are associated with specific biochemical abnormalities which are causal or contributing factors of the illness.
Margot Kidder born October 17, 1948 is a Canadian-American film and television actress best known for playing Lois Lane in the Superman movies of the 1970s and 1980s.
Massive niacin treatment in schizophrenia. Review of a nine-year study. OSMOND H, HOFFER A. Lancet. 1962 Feb 10;1(7224):316-9.
Treatment of Acute Schizophrenia With Vitamin Therapy, This study has been completed.
Sponsors and Collaborators: Beersheva Mental Health Center. Supported by a Hilton Family Foundation grant to International Schizophrenia Foundation. Therefore, this proposal is to study in a controlled manner carefully defined first onset schizophrenic patients using the protocol advocated by Osmond and Hoffer (1962) (high dose niacin).
Adventures in Psychiatry: The Scientific Memoirs of Dr. Abram Hoffer by Dr. Abram Hoffer, Kos Publishing Inc
Vitamin B-3 and Schizophrenia: Discovery, Recovery, Controversy by Abram Hoffer, MD Quarry Press, Kingston, Ontario Canada (1998) Review by Andrew W. Saul
Hoffer's Home Page -Orthomolecular Treatment of Cancer.
Hoffer's Home Page -The Schizophrenias
Abram Hoffer MD, PhD Interviewed by Peter Barry Chowka On Orthomolecular Medicine.
Linus Pauling Institute
Supplemental Ascorbate in the Supportive Treatment of Cancer: Prolongation of Survival Times in Terminal Human Cancer. Ewan Cameron and Linus Pauling. PNAS, October 1, 1976, vol. 73, no. 10, p3685-3689.
Supplemental Ascorbate in the Supportive Treatment of Cancer: Reevaluation of Prolongation of Survival Times in Terminal Human Cancer. Ewan Cameron and Linus Pauling. PNAS, September 1, 1978, vol. 75, no. 9, 4538-4542.
The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer, Ewan Camerona, a and Allan Campbellb, Chemico-Biological Interactions Volume 9, Issue 4, October 1974, Pages 285-315.
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S.N Engl J Med. 1979 Sep 27;301(13):687-90.
Jeanne A. Drisko, MD Riordan Endowed Professor of Orthomolecular Medicine, Director, Program in Integrative Medicine
Safety of Antioxidants During GYN Cancer Care. University of Kansas, June 2008
Principal Investigator:Jeanne Drisko, MD University of Kansas
Intravenously administered vitamin C as cancer therapy: three cases
Sebastian J. Padayatty, Hugh D. Riordan, Stephen M. Hewitt, Arie Katz, L. John Hoffer, and Mark Levine.CMAJ. 2006 March 28; 174(7): 937–942.
Mark A. Levine, M.D.Molecular and Clinical Nutrition Section, Chief Digestive Diseases Branch
NIDDK, National Institutes of Health Building 10, Room 4D52 Bethesda, MD 20892-1372
Study: Vitamin C May Fight Cancer Sept. 12, 2005 -- Vitamin C may have some cancer-fighting potential, new research shows.
Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use. Sebastian J. Padayatty, MRCP, PhD; He Sun, PhD, CBS; Yaohui Wang, MD; Hugh D. Riordan, MD; Stephen M. Hewitt, MD, PhD; Arie Katz, MD; Robert A. Wesley, PhD; and Mark Levine, MD. Ann Intern Med. 2004 Volume 140 Issue 7, Pages 533-537.
Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use Sebastian J. Padayatty, MRCP, PhD; He Sun, PhD, CBS; Yaohui Wang, MD; Hugh D. Riordan, MD; Stephen M. Hewitt, MD, PhD; Arie Katz, MD; Robert A. Wesley, PhD; and Mark Levine, MD Ann Intern Med. 2004;140:533-537.
Reevaluation of Ascorbate in Cancer Treatment: Emerging Evidence, Open Minds and Serendipity . Sebastian J Padayatty, MRCP, PhD and Mark Levine, MD, FACN
Journal of the American College of Nutrition, Vol. 19, No. 4, 423-425 (2000)
Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance (ascorbic acid / bioavailability) Mark Levine et al. Vol. 93, Issue 8, 3704-3709, April 16, 1996, "the current RDA of 60 mg daily should be increased to 200 mg daily, which can be obtained from fruits and vegetables. Safe doses of vitamin C are less than 1000 mg daily, and vitamin C daily doses above 400 mg have no evident value."
The Science of Vitamin C by Steve Hickey
Phyllis Bronson, Ph.D., the primary researcher Aspen Philanthropist. Degrees in neurobiochemistry and an extensive scientific background in biochemistry. I run a clinical practice in Aspen, Colorado, and am a research associate at The University of Denver, Department of Chemistry and Biochemistry. I conduct my chemical research in the physical chemistry laboratory of Dwight Smith, Ph.D., who also serves as a scientific advisor in much of my research. I am also on the faculty of both The American Academy of Environmental Medicine and The International Society of Orthomolecular Medicine.
The Cruciferous Choice: DIM or 13C? Phytonutrient Supplements for Cancer Prevention and Health Promotion - diindolyl-methane, indole-3-carbinol. Townsend Letter for Doctors and Patients, August, 2001 by Michael A. Zeligs
Breast Cancer Prevention and Iodine Supplementation by Jeffrey Dach MD
Bruice Kenton MD Board Certified Gynecologist. Natural Hormone Replacement Therapy with Bio-Identical Hormones
Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 Women. De Lignières B. et al. Climacteric. 2002 Dec;5(4):332-40. Paris, France. French Cohort Study showing no increased risk of breast cancer from bio-identical hormones.
Estrogen Therapy and Coronary-Artery Calcification. JoAnn E. Manson, M.D. et al. NEJM Volume 356:2591-2602 June 21, 2007 Number 25 NEJM study which shows that estrogen therapy prevents heart disease.
Mark Starr MD Type Two Hypothyroidism
Hypothyroidism Type Two and Thyroflex by Jeffrey Dach MD
Dr. Greenblatt is a dually board certified in child and adult psychiatry. He received his medical degree and completed his adult psychiatry residency at George Washington University in Washington D.C. He completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. Dr. Greenblatt is founder and Medical Director of Comprehensive Psychiatric Resources, Inc. and a clinical faculty member at Harvard Medical School, Department of Psychiatry.
About Walden Since its founding in 2003, Walden Behavioral Care has become a national leader in the treatment of eating disorders and psychiatric disorders.
Inositol treatment of obsessive-compulsive disorder. M Fux, J Levine, A Aviv and RH Belmaker
Ministry of Health Mental Health Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva, Israel.
Am J Psychiatry 1996; 153:1219-1221
Inositol and OCD By Frederick Penzel, Ph.D.
The Great Plains Laboratory helps children and adults with conditions such as autism & PDD, ADD/ADHD, Down's Syndrome with autistic-like symptoms, Fibromyalgia, Chronic Fatigue, MS or MS-like symptoms, Irritable Bowel Syndrome, Brain Fog, Depression, Psychosis, GI disorders, and many other diseases and conditions.
Dr. William Shaw received a Ph.D. in biochemistry and human physiology from the Medical University of South Carolina. He is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry. He has supervised large endocrinology, nutritional biochemistry, and toxicology and immunology departments in positions at the Center for Disease Control (CDC) and Smith Kline Laboratories in Atlanta. He was Director of Clinical Chemistry, Endocrinology and Toxicology at Children’s Mercy Hospital, the teaching hospital of the University of Missouri at Kansas City School of Medicine. Dr. Shaw is now the Director of The Great Plains Laboratory for Health, Nutrition and Metabolism in Lenexa, Kansas specializing in urine metabolic testing for autism spectrum disorders. He is author of “Biological Treatments for Autism and PDD” and is a frequent speaker at autism conferences worldwide. He is the stepfather of a child with autism and has helped thousands of parents and physicians successfully contribute to improving the lives of autistic children.
Biological Treatments for Autism and PDD, by William Shaw, Ph.D.
Abram Hoffer B3 Niacin for Schizophrenia
The Discovery of Kryptopyrrole and its Importance in Diagnosis of Biochemical Imbalances in Schizophrenia and in Criminal Behavior by Abram Hoffer, M.D., Ph.D. Journal of Orthomolecular Medicine: The Discovery of Kryptopyrrole and its Importance. Vol. 10, No. 1, 1995
What really Causes Schizophrenia by Harold Foster
Orthomolecular Treatment for Schizophrenia By Abram Hoffer Published 1999 McGraw-Hill Professional Schizophrenia
Schizophrenia & Orthomolecular Treatment Townsend Letter for Doctors and Patients, April, 2001 by Jule Klotter
Disclaimer click here: http://www.drdach.com/wst_page20.html
The reader is advised to discuss the comments on these pages with his/her personal physicians and to only act upon the advice of his/her personal physician. Also note that concerning an answer which appears as an electronically posted question, I am NOT creating a physician -- patient relationship. Although identities will remain confidential as much as possible, as I can not control the media, I can not take responsibility for any breaches of confidentiality that may occur. Finally, the material produced by myself may be reproduced for personal use, provided that appropriate credit is given.
Link to this article: http://jeffreydach.com/2007/05/06/jeffreydachdrdachhoffer.aspx
This article may be copied or reproduced on the internet provided a link and credit is given.
Copyright (c) 2008-2010 all rights reserved Jeffrey Dach MD, www.drdach.com disclaimer